Shelter Pharma Ltd
Shelter Pharma Ltd (SHELTER) last reported results for the quarter ended Mar 2026, with sales of ₹39.84 crore and net profit of ₹4.53 crore. The stock last traded at ₹38, a market capitalisation of ₹64 crore, on a P/E of 7.09. Over the past 52 weeks the stock has ranged between ₹23 and ₹46.5. Figures are as of 6 Oct 2026 and are not real time.
Shelter Pharma Ltd share price and key metrics
- Current price
- ₹38
- Market cap
- ₹64 cr
- Stock P/E
- 7.09
- Book value
- ₹46.1
- ROE
- 15.1%
- ROCE
- 20.4%
- Dividend yield
- 0.00%
- 52w high / low
- 46.5/23.0
Metrics as of 6 Oct 2026. Not real time.
Track Shelter Pharma Ltd
Cruxal reads every Shelter Pharma Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Shelter Pharma Ltd growth and returns
- 10 Years
- 10%
- 5 Years
- 27%
- 3 Years
- 26%
- TTM
- 44%
- 10 Years
- 68%
- 5 Years
- 196%
- 3 Years
- 15%
- TTM
- 25%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -1%
- 1 Year
- -14%
- 10 Years
- %
- 5 Years
- 21%
- 3 Years
- 18%
- Last Year
- 15%
Shelter Pharma Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹39.84 cr, up 49.8% from ₹26.6 cr a year earlier. Net profit was ₹4.53 cr, up 22.4% year on year.
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 17.02 | 19.13 | 19.31 | 20.71 | 24.06 | 26.6 | 33.29 | 39.84 |
| Expenses | 13.71 | 14.82 | 15.02 | 16.42 | 19.16 | 21.42 | 27.03 | 33.37 |
| Operating profit | 3.31 | 4.31 | 4.29 | 4.29 | 4.9 | 5.18 | 6.26 | 6.47 |
| OPM % | 19.45% | 22.53% | 22.22% | 20.71% | 20.37% | 19.47% | 18.80% | 16.24% |
| Other income | 0 | -0.45 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Interest | 0.01 | 0.01 | 0.05 | 0 | 0.07 | 0.06 | 0.06 | 0.05 |
| Depreciation | 0.08 | 0.08 | 0.12 | 0.13 | 0.1 | 0.17 | 0.19 | 0.22 |
| Profit before tax | 3.22 | 3.77 | 4.12 | 4.16 | 4.73 | 4.95 | 6.01 | 6.21 |
| Tax % | 25.47% | 25.46% | 24.76% | 25.00% | 25.16% | 25.05% | 25.29% | 27.05% |
| Net profit | 2.4 | 2.81 | 3.1 | 3.12 | 3.54 | 3.7 | 4.5 | 4.53 |
| EPS (₹) | 49.59 | 3.63 | 2.68 | 2.70 | 3.06 | 3.20 | 3.89 | 2.73 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Shelter Pharma Ltd annual results
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 50.64 | 73.02 |
| Operating profit | 0.15 | -0.7 | 0.24 | 0.19 | 3.05 | 8.15 | 8.79 | 10.07 | 12.73 |
| OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 22.01% | 19.89% | 17.43% |
| Net profit | 0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.2 | 7.24 | 9.03 |
| EPS (₹) | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 6.26 | 5.44 |
TTM is the trailing twelve months to the most recent quarter.
Shelter Pharma Ltd balance sheet
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 | 16.61 |
| Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 31.16 | 60.02 |
| Borrowings | 2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.58 | 1.04 | 0.80 |
| Other liabilities | 1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.51 | 4.58 | 6.80 |
| Total liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 | 84.23 |
| Fixed assets | 2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 5.96 | 7.14 |
| CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 | 0.68 | 0.68 |
| Other assets | 8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 41.70 | 76.41 |
| Total assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 | 84.23 |
As reported by the company. Total assets equal total liabilities by construction.
Shelter Pharma Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.96 | 5.42 | -12.48 |
| Cash from investing | 0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.43 | -7.13 | -14.55 |
| Cash from financing | 0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | 0.09 | 24.69 |
| Net cash flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 | -1.62 | -2.34 |
| Free cash flow | 0.00 | -0.32 | -0.29 | -0.08 | 0.00 | -2.81 | 2.77 | -14.07 |
| CFO / operating profit | 0% | -112% | -147% | 17% | 0% | -5% | 78% | -73% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Shelter Pharma Ltd operating ratios
| Per year | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 0.68% | — | 1.12% | 35.91% | 63.26% | 32.39% | 24.48% | 20.36% |
| Debtor days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.90 | 68.26 | 59.03 |
| Inventory days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 | 127.15 | 160.53 |
| Days payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 | 12.32 | 8.21 |
| Cash conversion cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.26 | 183.09 | 211.35 |
| Working capital days | 91.35 | 59.59 | 54.14 | 74.85 | 71.64 | 121.57 | 212.07 | 181.85 | 234.79 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Shelter Pharma Ltd shareholding pattern
Promoters held 44.38% at May 2026, down from 52.32% at Mar 2025.
| % held | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Nov 2025 | Mar 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 56.89% | 56.89% | 54.97% | 52.32% | 52.32% | 47.19% | 44.99% | 44.38% |
| Public | 43.11% | 43.12% | 45.03% | 47.68% | 47.68% | 52.82% | 55.00% | 55.61% |
| No. of shareholders | 836 | 868 | 1,119 | 1,153 | 1,094 | 1,093 | 1,060 | 1,089 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Shelter Pharma Ltd corporate filings
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Attached herewith Compliance Certificate forthe quarter ended 30th September, 2026
Read the full analysis - Shelter Pharma Limited's AGM approves regularization of Ms. Vinita Shivraj Gadhavi as Non-Executive Independent Director for a 5-year term from July 2026Company Updatelow impact
Cruxal's analysis: Shelter Pharma Limited has held its 19th AGM on September 29, 2026, and received…
Read the full analysis - Corporate Disclosure: Approval of Multiple Related Party Transactions and Director Appointment at Shelter Pharma Limited (2026 Annual General Meeting)AGM/EGMmedium impact
Cruxal's analysis: Shelter Pharma Limited's recent AGM results reveal the approval of several material…
Read the full analysis - Shareholder Meeting / Postal Ballot-Outcome of AGMAGM/EGMmedium impact
- Closure of Trading Window quarter ended 30th September, 2026.Insider Trading / SASTlow impact
- Shelter Pharma reports positive doctor feedback on product portfolioCompany Updatelow impact
Cruxal's analysis: Shelter Pharma has issued an intimation under Regulation 30 regarding positive feedback…
Read the full analysis - Shelter Pharma Limited Secures International Export Order for Nutraceutical Products Valued at 9.72 Lakh INRCompany Updatemedium impact
Cruxal's analysis: Shelter Pharma Limited has announced the receipt of an international purchase order from…
Read the full analysis - Shelter Pharma Ltd announces participation in Vishwa Ayurveda Parishad exhibitionCompany Updatelow impact
Cruxal's analysis: Shelter Pharma Ltd has filed an intimation under Regulation 30 of SEBI (LODR)…
Read the full analysis - Shelter Pharma Limited Announces 19th Annual General Meeting Scheduled for September 29, 2026AGM/EGMlow impact
Cruxal's analysis: Shelter Pharma Limited has issued a formal notice regarding its 19th Annual General…
Read the full analysis - Shelter Pharma Limited Announces Board Appointments and Schedules 19th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Shelter Pharma Limited has announced the regularization of Dr. Vinita Shivraj Gadhvi as a…
Read the full analysis - Shelter Pharma Limited regularizes Dr. Vinita Shivraj Gadhavi as Non-Executive Independent DirectorCompany Updatelow impact
Cruxal's analysis: Shelter Pharma Limited has announced the regularization of Dr. Vinita Shivraj Gadhavi as…
Read the full analysis - Shelter Pharma Limited Announces Board Meeting Outcome: Appointment of Independent Director and AGM SchedulingOtherslow impact
Cruxal's analysis: Shelter Pharma Limited has announced the regularization of Dr. Vinita Shivraj Gadhavi as…
Read the full analysis - Shelter Pharma Limited Announces Successful Dispatch of Export Order to Sudan and Identifies 50 crore Revenue OpportunityCompany Updatehigh impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed and dispatched an export order of…
Read the full analysis - Shelter Pharma Limited completes and dispatches export order worth approximately 1.20 crore INR to SudanCompany Updatemedium impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed and dispatched an export order for…
Read the full analysis - Shelter Pharma Ltd announces new product launch under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Shelter Pharma Ltd has issued an intimation regarding the launch of a new product in…
Read the full analysis - Shelter Pharma Limited completes and dispatches export order to Bangladesh worth approximately 10.3 lakh INRCompany Updatelow impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed the manufacturing and dispatch of an…
Read the full analysis - Shelter Pharma Limited completes and dispatches export order worth approximately 87 lakh INR to SudanCompany Updatemedium impact
Cruxal's analysis: Shelter Pharma Limited has successfully completed and dispatched an export order for 'All…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.